Emergent BioSolutions Pharmaceutical Products

Emergent BioSolutions is a prominent American multinational biopharmaceutical company that specializes in the development and manufacture of vaccines, therapeutics, and medical countermeasures against infectious diseases and public health threats. The company is perhaps best known for its production of the Narcan (naloxone) nasal spray and anthrax vaccines, which are critical components of national stockpiles.

Founded in 1998, the company has grown into a major player in the global health security market. While it operates as an independent, publicly traded entity, it maintains significant contractual relationships with various government agencies, particularly in the United States. Its manufacturing operations are concentrated in Maryland, Michigan, and Canada, though it utilizes a global supply chain to support its diverse portfolio of life-saving medical products.